Abstract
Sarcoidosis is a systemic disease that involves the lungs in almost all afflicted individuals. The pathologist plays a major and essential role in the management of patients with sarcoidosis because definitive establishment of the diagnosis depends on the microscopic examination of tissue. The nature of this enigmatic disease has perplexed physicians since the first description of its histologic features by Boeck in 1905. Interest in sarcoidosis has stimulated an enormous amount of research into its etiology, pathogenesis, epidemiology, abnormalities of the immune system, and clinical aspects. These efforts have resulted in thousands of publications1,2 and 12 international conferences on sarcoidosis and other granulomatous disorders.3–5 Yet, despite the substantial increase in knowledge about the various aspects of sarcoidosis gained during the past 100 years, its etiology remains entirely unknown. Many excellent publications present comprehensive and updated coverage of its immunological and clinical and radiographic features, epidemiology, abnormal physiology, diagnostic modalities, treatment, etc.6–12
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Mandel W, Thomas JH, Carman CT, McGovern JP. Bibliography on sarcoidosis 1878–1963. Washington, D.C.: U.S. Public Health Service Publication No. 1213, 1964.
Ito Y. Bibliography on sarcoidosis. Tokyo: World Education, 1981.
Chrétien J, Marsac J, Saltiel JC, eds. Sarcoidosis and other granulomatous disorders. Ninth international conference on sarcoidosis and other granulomatous disorders. Paris: Pergamon Press, 1983.
Johns CJ, ed. Tenth international conference on sarcoidosis and other granulomatous disorders. Ann NY Acad Sci 1986; 465.
Grassi C, Rizzato G, Pozzi E, eds. Sarcoidosis and other granulomatous disorders. Proceedings of the XI world congress on sarcoidosis and other granulomatous disorders. Amsterdam: Excerpta Medica, 1988.
James DG, Jones Williams W. Sarcoidosis and other granulomatous disorders. Philadelphia: WB Saunders, 1985.
Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA. Interstitial lung diseases of unknown cause, Part 1. N Engl J Med 1984; 310: 154–166.
Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA. Interstitial lung diseases of unknown cause, Part 2. N Engl J Med 1984; 310: 235–244.
Fanburg BL, ed. Sarcoidosis and other granulomatous diseases of the lung. New York: Marcel Dekker, 1983.
Berkmen YM. Radiologic aspects of intrathoracic sarcoidosis. Semin Roentgenol 1985; 20: 356–375.
Sharma OP. Sarcoidosis. DM 1990; 36: 474–535.
Thomas PD, Hunninghake GW. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 1987; 135: 747–760.
James DG, Turiaf J, Hosoda Y, et al. Description of sarcoidosis: Report of the committee on classification and definition. In: Siltzbach LE, ed. Seventh international conference on sarcoidosis and other granuloma-tous disorders. Ann NY Acad Sci 1976; 278: 742.
Scadding JG. Further observations on sarcoidosis associated with M. tuberculosis infection. In: Levinsky L, Macholda F, eds. Proceedings of the fifth international conference on sarcoidosis and other granulomatous disorders. Prague: Universita Karlova, 1971: 89–92.
Zettergren L. Lymphogranulomatosis benigna. Acta Soc Med Ups (suppl 5) 1954; 5: 1–180.
Vänek J, Schwarz J. Demonstration of acid-fast rods in sarcoidosis. Am Rev Respir Dis 1970; 101: 395–400.
Mankiewicz E, van Walbeek M. Mycobacteriophages: Their role in tuberculosis and sarcoidosis. Arch Environ Health 1962; 5: 122–128.
Chapman, JS, Speight M. Further studies of mycobacterial antibodies in the sera of sarcoidosis patients. Acta Med Scand (Suppl) 1964; 425: 61–66.
Siltzbach LE. Sarcoidosis and mycobacteria. Am Rev Respir Dis 1968; 97: 1–8.
Kok TC,Haasjes JG, Splinter TAW, ten Kate FJ. Sarcoid-like lymphadenopathy mimicking metastatic testicular cancer. Cancer 1991; 68: 1845–1847.
Toner GC, Bosl GL. Sarcoidosis, “sarcoid-like lymphadenopathy,” and testicular germ cell tumors. Am J Med 1990; 89: 651–56.
Familial associations in sarcoidosis: A report to the Research Committee of the British Thoracic and Tuberculosis Association. Tubercle 1973; 54: 87–98.
Brewerton DA, Cockburn C, James DCO, James DG, Neville E. HLA antigens in sarcoidosis. Clin Exp Immunol 1977; 27: 227–229.
James DG, Jones Williams W. Sarcoidosis and other granulomatous disorders. Philadelphia: WB Saunders, 1985: 220.
Sharma OP, Neville E, Walker AN, James DG. Familial sarcoidosis: A possible genetic influence. In: Siltzbach LE, ed. Seventh international conference on sarcoidosis and other granulomatous disorders. Ann NY Acad Sci 1976; 278: 386–400.
Harf RA, Ethevenaux C, Gleize J, Perrin-Fayolle M, Guerin JC, 011agnier C. Reduced prevalence of smokers in sarcoidosis: Results of a case control study. In: Johns CJ, ed. Tenth international conference on sarcoidosis and other granulomatous disorders. Ann NY Acad Sci 1986; 465: 625–631.
Valeyre D, Soler P, Clerici C, et al. Smoking and pulmonary sarcoidosis: Effect of cigarette smoke on prevalence, clinical manifestations, alveolitis and evolution of the disease. Thorax 1988; 43: 516–524.
Bresnitz EA, Israel H, Stolley PD, Soper K. Possible risk factors for sarcoidosis: A case control study. In: Johns CJ, ed. Tenth international conference on sarcoidosis and other granulomatous disorders. Ann NY Acad Sci 1986; 465: 632–642.
Adams DO. The biology of the granuloma. In: loachim HL, ed. Pathology of granulomas. New York: Raven Press, 1983: 1–20.
James DG, Neville E. Pathobiology of sarcoidosis. Pathobiol Annu 1977; 7: 31–61.
Adams DO. The granulomatous inflammatory response. Am J Pathol 1976; 84: 163–192.
Tanaka A, Emori K, Nagao S, et al. Epithelioid granuloma formation requiring no T-cell function. Am J Pathol 1982; 106: 165–170.
Jagadha V, Andavolu RH, Huang CT. Granulomatous inflammation in the acquired immune deficiency syndrome. Am J Clin Pathol 1985; 84: 598–602.
Boros DL. Granulomatous inflammation. Prog Allergy 1978; 24: 184–267.
Epstein WL. Granuloma formation in man. Pathobiol Annu 1977; 7: 1–30.
Spector WG. The macrophage: Its origins and role in pathology. Pathobiol Annu 1974; 4: 33–64.
Spector WG. Granulomatous hypersensitivity. Prog Allergy 1967; 11: 36–88.
Crystal RG, Roberts WC, Hunninghake GW, Gadek JE, Fulmer JD, Line BR. Pulmonary sarcoidosis: A disease characterized and perpertuated by activated lung T lymphocytes. Ann Intern Med 1981; 94: 73–94.
Hunninghake GW, Fulmer JD, Young RC, Gadek JE, Crystal RG. Localization of the immune response in sarcoidosis. Am Rev Respir Dis 1979; 120: 49–57.
Hunninghake GW, Crystal RG. Pulmonary sarcoidosis: A disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 1981; 305: 429–434.
Rosen Y, Athanassiades TJ, Moon S, Lyons HA. Nongranulomatous interstitial pneumonitis in sarcoidosis: relationship to the development of epithelioid granulomas. Chest 1978; 74: 122–125.
Semenzato G, Pezzutto G, Chilossi M, Ossi E, Angi MR, Cipriani A. Immunohistological study in sarcoidosis: evaluation at different sites of disease activity. Clin Immunol Immunopathol 1984; 30: 29–40.
Hunninghake GW, Crystal RG. Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis: Site of increased antibody production and role of T lymphocytes. J Clin Invest 1981; 67: 86–92.
Semenzato G. The sarcoid granuloma formation-immunology. In: Grassi C, Rizzato G, Pozzi E, eds. Sarcoidosis and other granulomatous disorders. Proceedings of the XI world congress on sarcoidosis and other granulomatous disorders. Amsterdam: Excerpta Medica, 1988: 73–87.
van Furth R, Cohn ZA, Hirsch JG, Humphrey JH, Spector WG, Langevoort HL. The mononuclear phagocyte system: A new classification of macrophages, monocytes and their precursor cells. Bull W-HO 1972; 46: 845–852.
Spector WG. Chronic inflammation. In: Zweifach BW, Grant L, McCluskey RT, eds. The inflammatory process, Vol.3, 2d Ed. New York: Academic Press, 1974: 277–290.
Wilkinson PC. Chemotaxis and inflammation. Edinburgh: Churchill Livingston, 1974.
Ward PA, Becker EL. Biology of leukotaxis. Rev Physiol Biochem Pharmacol 1977; 77: 125–148.
van Furth R, Fedorko ME. Ultrastructure of mouse mononuclear phagocytes in bone marrow: colonies grown in vitro. Lab Invest 1976; 34: 440–450.
Nichols BA, Bainton DF. Ultrastructure and cytochemistry of mononuclear phagocytes. In: van Furth R, ed. Mononuclear phagocytes in immunity, infection and pathology. Oxford: Blackwell, 1975: 17–56.
van Furth R. Mononuclear phagocytes in inflammation. In: Vane JR, Ferreira SH, eds. Handbook of experimental pharmacology, Vol. 50, Part 1. Berlin: Springer Verlag, 1978: 68–108.
Stewart CC, Lin HS. Macrophage growth factor and its relationship to colony stimulating factor. J Reticuloendothel Soc 1978; 23: 269–285.
van der Zeijst BAM, Stewart CC, Schlesinger S. Proliferative capacity of mouse peritoneal macrophages in vitro. J Exp Med 1978; 147: 1253–1266.
Cohn ZA. The activation of mononuclear phagocytes: Fact, fancy and future. J Immunol 1978; 121: 813–816.
Nelson DS. Macrophages and cell-mediated immunity. In: Gadebusch HH, ed. Phagocytes and cellular immunity. Cleveland: CRC Press, 1979: 57–100.
Keller R. Mononuclear phagocytes and antitumor resistance: A discussion. In: James K, McBride A, Stuart A, eds. Symposium on the macrophage and cancer. Edinburgh: University of Edinburgh, 1979: 31–49.
North RJ. The concept of the activated macrophage. J Immunol 1978; 121: 806–809.
Meltzer MS, Ruco LP, Boraschi B, Nacy CA. Macrophage activation for tumoricidal toxicity: analysis of intermediary reactions. J Reticuloendothel Soc 1979; 26: 403–416.
Lasser A. The mononuclear phagocytic system. Hum Pathol 1983; 14: 108–126.
Pierce CW. Macrophages: Modulators of immunity. Am J Pathol 1980; 98: 10–28.
Unanue ER. The regulatory role of macrophages in antigen stimulation, Part 2: symbiotic relationships between lymphocytes and macrophages. Adv Immunol 1981; 31: 1–136.
Unanue ER. Secretory function of mononuclear phagocytes. Am J Pathol 1976; 83: 396–417.
Hunninghake GW. Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis. Am Rev Respir Dis 1984; 129: 569–572.
Spector WG, Mariano M. Macrophage behaviour in experimental granulomas. In: van Furth R, ed. Mononuclear phagocytes in infection, immunity and pathology. Oxford; Blackwell, 1975: 927–942.
Hirsch BC, Johnson WC. Concepts of granulomatous inflammation. Int J Dermatol 1984; 23: 90–100.
Soler P,Basset F, Bernaudin JF, Chrétien J. Morphology and distribution of the cells of a sarcoid granuloma: Ultrastructural study of serial sections. In: Siltzbach LE, ed. Seventh international conference on sarcoidosis and other granulomatous disorders. Ann NY Acad Sci 1976; 278: 147–160.
Chambers TJ. Multinucleate giant cells. J Pathol 1978; 126: 125–148.
Papadimitriou JM, Sforsina D, Papaelias L. Kinetics of multinucleate giant cell formation and their modification by various agents in foreign body reactions. Am J Pathol 1973; 73: 349–364.
Black MM, Epstein WL. Formation of multinucleate giant cells in organized epithelioid cell granulomas. Am J Pathol 1974; 74: 263–274.
Ginns LC, Goldenheim PD, Burton RC et al. T-lymphocyte subsets in peripheral blood and lung lavage in idiopathic pulmonary fibrosis and sarcoidosis: Analysis by monoclonal antibodies and flow cytometry. Clin Immunol Immunopathol 1982; 25: 11–20.
Ward PA, Remold HG, David JR. Leukotactic factor produced by sensitized lymphocytes. Science 1969; 163: 1079–1081.
Oppenheim JJ. Lymphokines. In: Oppenheim JJ, Rosenstreich M, Potter M, eds. Cellular functions in immunity and inflammation. New York: Elsevier/North Holland, 1981: 259–282.
David JR, Rocklin RE. Lymphocyte mediators “the lymphokines”. In: Samter M, ed. Immunological diseases, Vol. 1. Boston: Little, Brown, 1978: 307–324.
Rocklin RE. Products of activated lymphocytes: Leukocyte inhibitory factor (LIF) distinct from migration inhibition factor(MIF). J Immunol 1974; 112: 1461–1466.
Hunninghake GW, Bedell GN, Zavala DC, Monnick M, Brady M. Role of interleukin-2 release by lung T cells in active pulmonary sarcoidosis. Am Rev Respir Dis 1983; 128: 634–638.
Byrne EB, Evans AS, Fouts DW, Israel HL. Serological hyperreactivity to Epstein-Barr virus and other viral antigens in sarcoidosis. In: Iwai K, Hosoda Y, eds. Proceedings of the sixth international conference on sarcoidosis. Baltimore: University Park Press, 1974: 218–225.
Lawrence EC, Martin RR, Blease RM, et al. Increased bronchoalveolar IgG secreting cells in interstitial lung diseases. N Engl J Med 1980; 302: 1186–1188.
Berman B, Fox JL, Teirstein AS. Quantitation of cutaneous Langerhans cells of sarcoidosis patients. In: Johns CJ, ed. Tenth international conference on sarcoidosis and other granulomatous disorders. Ann NY Acad Sci 1986; 465: 250–259.
James DG. Granulomatous disorders which mimic sarcoidosis. In: Iwai K, Hosoda Y, eds. Proceedings of the sixth international conference on sarcoidosis. Baltimore: University Park Press, 1974: 132–135.
James DG. Sarcoidosis. DM 1970: February (special issue).
Semenzato G, Pezzutto A, Chisoli M, Pizzola G. Redistribution of lymphocytes in the lymph nodes of patients with sarcoidosis. N Engl J Med 1982; 306: 48–49.
Modlin RL, Hofman FM, Meyer PR, Sharma OP, Taylor CR, Rea TH. In situ demonstration of T lymphocyte subsets in granulomatous inflammation: Leprosy, rhinoscleroma and sarcoidosis. Clin Exp Immunol 1983; 51: 430–438.
Modlin RL, Hofman FM, Sharma OP, Gottlieb B, Taylor CR, Rea TH. Demonstration in situ of subsets of T-lymphocytes in sarcoidosis. Am J Dermatopathol 1984; 6: 423–427.
van Maarsseven A, Mullink H, Alons C, Stam J. Distribution of T-lymphocyte subsets in different portions of sarcoid granulomas: Immunohistologic analysis with monoclonal antibodies. Hum Pathol 1986; 17: 493–500.
Van Den Oord JJ, DeWolf-Peeters C, Facchetti F, Des-met VJ. Cellular composition of hypersensitivity type granulomas. Hum Pathol 1984; 15: 559–565.
Ricker W, Clark M. Sarcoidosis: a clinico-pathologic review of 300 cases, including 22 autopsies. Am J Clin Pathol 1949; 19: 725–749.
Rosen Y, Vuletin JC, Pertschuk LP, Silverstein E. Sarcoidosis from the pathologist’s vantage point. Pathol Annu 1979; 14 (part 1): 405–439.
Cree IA, Nurbhai S, Milne G, Swanson Beck J. Cell death in granulomata: The role of apoptosis. J Clin Pathol 1987; 40: 1314–1319.
Carlens E, Hanngren A, Ivemark B. The concomitance of feverish onset of sarcoidosis and necrosis formation in the lymph nodes. In: Iwai K, Hosoda Y, eds. Proceedings of the sixth international conference on sarcoidosis. Baltimore: University Park Press, 1974: 409–412.
Dannenberg AM, Jr., Sugimoto M. Liquefaction of caseous foci in tuberculosis. Am Rev Respir Dis 1976; 113: 257–259.
Medlar EM. A study of the process of caseation in tuberculosis. Am J Pathol 1926; 2: 275–290.
Rich AR. The pathogenesis of tuberculosis, 2d Ed. Springfield: Thomas, 1951: 734–742.
Zak F. Contribution to the origin, development and experimental production of laminated calcino-siderotic Schaumann bodies. Acta Med Scand (suppl) 1964; 425: 21–24.
Jones Williams W. The nature and origin of Schaumann bodies. J Pathol Bacteriol 1960; 79: 193–201.
Visscher D, Churg A, Katzenstein AA. Significance of crystalline inclusions in lung granulomas. Mod Pathol 1988; 1: 415–419.
Reid JD, Andersen ME. Calcium oxalate in sarcoid granulomas. Am J Clin Pathol 1988; 90: 545–558.
Cain H, Kraus B. The ultrastructure and morphogenesis of asteroid bodies in sarcoidosis and other granulo-matous disorders. In: Williams JW, Davies BH eds. Eighth international conference on sarcoidosis and other granulomatous diseases. Cardiff: Alpha Omega, 1980: 30–37.
Jones Williams W, Williams D. “Residual bodies” in sarcoid and sarcoid-like granulomas. J Clin Pathol 1967; 20: 574–577.
Hamazaki T. Über ein Neues, säuerfeste Substanz führendes Spindelkörperchen der Menschlichen Lymphdrüsen. Virchows Arch (Pathol Anat) 1938; 301: 490–522.
Carter CJ, Gross MA. The selective staining of curious bodies in the lymph nodes as a means for the diagnosis of sarcoid. Stain Technol 1969; 44: 1–4.
Baro C, Butt CG. Hamazaki-Wesenberg bodies in sarcoidosis. Lab Med Bull Pathol 1970; 102: 281.
Boyd JF, Valentine JC. Unidentified yellow bodies in human lymph nodes. J Pathol 1970; 102: 58–60.
Doyle WF, Brahman HD, Burgess JH. The nature of the yellow-brown bodies in peritoneal lymph nodes. Histochemical and electron microscopic evaluation of these bodies in a case of suspected sarcoidosis. Arch Pathol 1973; 96: 320–326.
Sieracki JC, Fisher ER. The ceroid nature of so-called “Hamazaki-Wesenberg” bodies. Am J Clin Pathol 1973; 59: 248–253.
Boutet M. Etude ultrastructurale et histochimique des corps d’Hamazaki-Wesenberg dans la sarcoidose ganglionaire. Ann Anat Pathol 1975; 20: 201–212.
Wesenberg W. On acid-fast Hamazaki spindle bodies in sarcoidosis of lymph nodes and on double refractile cell inclusions in sarcoidosis of the lungs. Arch Klin Exp Dermatol 1966; 227: 101–107.
Vuletin JC, Rosen Y. Nature of pseudo-fungal budding structures (Hamazaki-Wesenberg bodies) and asteroid bodies in sarcoidosis (abstract). Am J Clin Pathol 1977; 68: 99.
Senba M, Kawai K. Nature of yellow-brown bodies. Histochemical and ultrastructural studies on the brown pigment. Zentralbl Allg Pathol Anat 1989; 135: 351–355.
Hall M, Eusebi V. Yellow-brown spindle bodies in mesenteric lymph nodes: A possible relationship with melanosis coli. Histopathology 1978; 2: 47–52.
Spencer H. Pathology of the lung. 4th Ed. Oxford: Pergamon Press, 1985: 828–829.
James DG, Neville E, Siltzbach LE, et al. A worldwide review of saroicdosis. In: Siltzbach LE, ed. Seventh international conference on sarcoidosis and other granulomatous disorders. Ann NY Acad Sci 1976; 278: 321–334.
Rosen Y, Amorosa JK, Moon S, Cohen J, Lyons HA. Occurrence of lung granulomas in patients with stage 1 sarcoidosis. AJR 1977; 129: 1083–1085.
Eule H. Findings by lung biopsy in patients with Löfgren’s syndrome. In: Levinsky L, Macholda F, eds. Proceedings of the fifth international conference on sarcoidosis and other granulomatous disorders. Prague: Universita Karlova, 1971; 469–471.
Freiman DG. The pathology of sarcoidosis. Semin Roentgenol 1985; 20: 327–339.
James DG, Jones Williams W. Sarcoidosis and other granulomatous disorders. Philadelphia: WB Saunders, 1985: 46–53.
Löfgren S. Erythema nodosum: studies on aetiology and pathogenesis in 185 adult cases. Acta Med Scand 1946(suppl 174); 124: 1–197.
Winterbauer RH, Moore KD. A clinical interpretation of bilateral hilar adenopathy. Ann Intern Med 1973; 78: 65–71.
James DG, Jones Williams W. Sarcoidosis and other granulomatous disorders. Philadelphia: WB Saunders, 1985: 49.
Chang JC, Driver AG, Townsend CA, Kataria YP. Hemoptysis in sarcoidosis. Sarcoidosis 1987; 4: 49–54.
Johns CJ, Schonfeld SA, Scott PP. The course and management of 53 patients with hemoptysis in sarcoidosis. In: Grassi C, Rizzato G, Pozzi E, eds. Sarcoidosis and other granulomatous disorders. Proceedings of the XI world congress on sarcoidosis and other granulomatous disorders. Amsterdam: Excerpta Medica, 1988: 417–420.
Carrington CB, Gaensler EA, Mikus JP, Schachter AW, Burke GW, Goff AM. Structure and function in sarcoidosis. In: Siltzbach LE, ed. Seventh international conference on sarcoidosis and other granulomatous disorders. Ann NY Acad Sci 1976; 278: 265–283.
Huang CT, Heurich AE, Rosen Y, Moon S, Lyons HA. Pulmonary sarcoidosis. Roentgenographic, functional and pathologic considerations. Respiration 1979; 37: 337–345.
Smellie H, Hoyle G. The natural history of pulmonary sarcoidosis. Q J Med 1960; 29: 539–558.
Daniel TM. Sarcoidosis. In: Baum GL, Wolinsky E, eds. Textbook of pulmonary diseases. 3rd Ed. Boston: Little Brown, 1983: 685–701.
Fraser RG, Pare JAP. Diagnosis of disease of the chest. 2d Ed. Philadelphia: WB Saunders, 1979: 1675–1689.
Longcope WT, Freiman DG. A study of sarcoidosis. Medicine (Baltimore) 1952; 31: 1–132.
Rosen Y, Moon S. Unpublished data.
Lacronique J, Bernaudin JF, Soler P, et al. Alveolitis and granulomas: Sequential course in pulmonary sarcoidosis. In: Chrétien J, Marsac J, Saltiel JC, eds. Sarcoidosis and other granulomatous disorders. Ninth international conference on sarcoidosis and other granulomatous disorders. Paris: Pergamon, 1983: 36–42.
Angi MR, Ossi E, Secchi AG, et al. The conjunctiva as a primary site of involvement in sarcoidosis. In: International Committee on Sarcoidosis, 10th international conference on sarcoidosis and other granulomatous disorders (abstracts). Baltimore, 1984: 77.
Daniele RP, Elias JA, Epstein PE, Rossman MD. Bronchoalveolar lavage: Role in the pathogenesis, diagnosis and management of interstitial lung disease. Ann Intern Med 1985; 102: 93–108.
Campbell DA, Poulter LW, Du Bois RM. Immunocompetent cells in bronchoalveolar lavage reflect the cell populations in transbronchial biopsies in pulmonary sarcoidosis. Am Rev Respir Dis 1985; 132: 1300–1306.
Unanue ER, Benacerraf B. Immunologic events in experimental hypersensitivity granulomas. Am J Pathol 1973; 71: 34O - 364.
Spector WG, Heesom N. The production of granulo-mata by antigen-antibody complexes. J Pathol 1969; 98: 31–39.
Hunninghake GW, Kawanami O, Ferrans VJ, Young RC, Roberts WC, Crystal RG. Characterization of the inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease. Am Rev Respir Dis 1981; 123: 407–412.
Halsam PL, Turton CWG, Heard B, Lukoszek A, Collins J V. Bronchoalveolar lavage in pulmonary fibrosis: Comparison of cells obtained with lung biopsy and clinical features. Thorax 1980; 35: 9–18.
Paradis IL, Rogers RM, Rabin BS, Dauber JH. Lymphocyte phenotypes in bronchoalveolar lavage and lung tissue in sarcoidosis. In: Johns CJ, ed. Tenth international conference on sarcoidosis and other granuloma-tous disorders. Ann NY Acad Sci 1986; 465: 148–156.
Reynolds HY, Newhall HH. Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J Lab Clin Med 1974; 84: 559–573.
Hunninghake GW, Gadek JE, Kawanami O, Ferrans VJ, Crystal RG. Inflammatory and immune processes in the human lung in health and disease: Evaluation by bronchoalveolar lavage. Am J Pathol 1979; 97: 149–206.
Crapo JD, Barry BE, Gehr P, Bachofen M, Weibel ER. Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis 1982; 126: 332–337.
Keogh BA, Hunninghake GW, Line BR, Crystal RG. The alveolitis of pulmonary sarcoidosis: Evaluation of natural history and alveolitis dependent changes in lung function. Am Rev Respir Dis 1983; 128: 256–265.
Israel-Biet D, Venet A, Chrétien J. Persistent high alveolar lymphocytosis as a predictive criterion of chronic pulmonary sarcoidosis. In: Johns CJ, ed. Tenth international conference on sarcoidosis and other granuloma-tous disorders. Ann NY Acad Sci 1986; 465: 395–406.
Costabel U, Bross KJ, Guzman J, Nilles A, Rühle KH, Matthys, H. Predictive value of bronchoâlveolar T cell subsets for the course of pulmonary sarcoidosis. In: Johns CJ, ed. Tenth international conference on sarcoidosis and other granulomatous disorders. Ann NY Acad Sci 1986; 465: 418–426.
Takahashi M. Histopathology of sarcoidosis and its immunological bases. Acta Pathol Jpn 1970; 20: 171–182.
Teilum G. Morphogenesis and development of sarcoid lesions. Similarities to the group of collagenosis. Acta Med Scand (Suppl) 1964; 425: 14–18.
Addrizzo JR, Minkowitz S, Lyons HA. Triple biopsy in the diagnosis of sarcoidosis. In: Levinsky L, Macholda F, eds. Proceedings of the fifth international conference on sarcoidosis and other granulomatous disorders. Prague: Universita Karlova, 1971: 476 479.
Rosen Y, Moon S, Huang CT, Gourin A, Lyons HA. Granulomatous pulmonary angiitis in sarcoidosis. Arch Pathol Lab Med 1977; 101: 170–174.
Levine BW, Saldana M, Hutter AM. Pulmonary hypertension in sarcoidosis. Am Rev Respir Dis 1971; 103: 413–417.
Smith LJ, Lawrence JB, Katzenstein AA. Vascular sarcoidosis: a rare cause of pulmonary hypertension. Am J Med Sci 1983; 285: 38–44.
Crissman JD, Koss M, Carson RP. Pulmonary veno-occlusive disease secondary to granulomatous venulitis. Am J Surg Pathol 1980; 4: 93–99.
Hoffstein V, Ranganathan N, Mullen JBM. Sarcoidosis simulating pulmonary veno-occlusive disease. Am Rev Respir Dis 1986; 134: 809–811.
Portier F, Lerebours-Pigeonniere G, Thiberville L, et al. Sarcoïdose simulant une maladie veino-occlusive pulmonaire. Rev Mal Resp 1991; 8: 101–102.
Turiaf J, Battesti P, Marland P, Basset F, Amouroux F. Sarcoidosis involving large pulmonary arteries. In: Williams JW, Davies BH, eds. Eighth international conference on sarcoidosis and other granulomatous diseases. Cardiff: Alpha Omega, 1980: 3–8.
Freiman DG, Hardy HL. Beryllium disease. Hum Pathol 1970; 1: 25–44.
Kitaichi M, Izumi T. Comparative pulmonary pathology of sarcoidosis, chronic beryllium disease and hypersensitivity pneumonitis based on open lung biopsy specimens. In: International Committee On Sarcoidosis, 10th international conference on sarcoidosis and other granulomatous disorders (abstracts). Baltimore, 1984; 65.
Mikami R, Sekiguchi M, Ryuzin Y, et al. Changes in peripheral vasculature of various organs of patients with sarcoidosis-possible role of microangiopathy. Heart Vessels 1986; 2: 129–139.
Mochizuki I, Kobayashi T, Wada R, et al. Vascular lesions in the biopsied bronchus of patients with sarcoidosis: Changes of the endothelial cells in aggregation of eosinophils. Sarcoidosis 1990; 7: 35–41.
Takemura T, Matsui Y, Oritsu M, et al. Pulmonary vascular involvement in sarcoidosis: Granulomatous angiitis and microangiopathy in transbronchial lung biopsies. Virchows Archiv [A] 1991; 418: 361–368.
Littler LPW. Bronchoscopy in sarcoidois. In: Levinsky L, Macholda F, eds. Proceedings of the fifth international conference on sarcoidosis and other granuloma-tous disorders. Prague: Universita Karlova, 1971: 463–465.
Siltzbach LE, Cahn LR. Random biopsy of bronchial and palatal mucosa in the diagnosis of sarcoidosis. In: Lofrgren S, ed. Proceedings of the third international conference on sarcoidosis. Acta Med Scand 1964(suppl); 425: 230–233.
Sharma OP, Izumi T. The importance of airway obstruction in sarcoidosis. Sarcoidosis 1988; 5: 119–120.
Miller A, Teirstein AS, Jackler I, Siltzbach LE. Evidence of airway involvement in late pulmonary sarcoidosis using flow-volume curves and nitrogen washout. In: Iwai K, Hosoda Y, eds. Proceedings of the sixth international conference on sarcoidosis. Baltimore: University Park, 1974: 421–424.
Olsson T, Björnstad-Petersen H, Stjernberg NL. Bronchostenosis due to sarcoidosis. Chest 1979; 75: 663–666.
Miller A, Brown LK, Teirstein AS. Fixed upper airway obstruction (UAO) caused by bilateral bronchial stenosis in sarcoidosis. In: International Committee On Sarcoidosis. Tenth international conference on sarcoidosis and other granulomatous disorders. Abstracts. Baltimore, 1984: 86.
Hadfield JW, Page RL, Flower CDR, Stark JE. Localized airways narrowing in sarcoidosis. Thorax 1982; 37: 443–447.
Chusid E., Siltzbach LE. Sarcoidosis of the pleura. Ann Intern Med 1974; 81: 190–194.
Wilen SB, Rabinowitz JG, Ulreich S, Lyons HA. Pleural involvement in sarcoidosis. Am J Med 1974; 57: 200–209.
Beekman JF, Zimmet SM, Chun BK, Miranda AA, Katz S. Spectrum of pleural involvement in sarcoidosis. Arch Intern Med 1976; 136: 323–330.
Vracko R. Significance of basal lamina for regeneration of injured lung. Virchows Arch (Pathol Anat) 1972; 355: 264–274.
Madri JA, Furthmayr H. Collagen polymorphism in the lung: An immunochemical study of pulmonary fibrosis. Hum Pathol 1980; 11: 353–366.
Editorial. Collagen in idiopathic pulmonary fibrosis. Lancet 1979;ii2:1277–1278.
Rennard SI, Hunninghake GW, Bitterman PB, Crystal RG. Production of fibronectin by the human alveolar macrophage: Mechanism for the recruitment of fibroblasts to the site of tissue injury in interstitial lung diseases. Proc Natl Acad Sci USA 1981; 78: 7147–7151.
Ruoslahti E, Enegvall E, Hayman EG. Fibronectin: current concepts of its structure and functions. Collagen Rel Res 1981; 1: 95–128.
Bitterman PB, Rennard SI, Hunninghake GW. Human alveolar macrophage growth factor for fibroblasts: regulation and partial characterization. J Clin Invest 1982; 70: 806–822.
Mayock RL, Bertrand P, Morisson CE, Scott JH. Manifestations of sarcoidosis. Am J Med 1963; 35: 67–89.
Israel HL, Ostrow A. Sarcoidosis and aspergilloma. Am J Med 1969; 47: 243–250.
Fresko D, Lazarus SS. Reactive systemic amyloidosis complicating long-standing sarcoidosis. NY State J Med 1982; 82: 232–234.
Swanton RH, Peters DK, Burn JI. Sarcoidosis and amyloidosis. Proc R Soc Med 1971; 64: 1002–1003.
Sharma OP, Koss M, Buck F. Sarcoidosis and amyloidosis: is the association causal or coincidental? Sarcoidosis 1987: 4: 139–141.
R¢mer FK. Sarcoidosis and cancer: A prospective study. In: Grassi C, Rizzato G, Pozzi E, eds. Sarcoidosis and other granulomatous disorders. Proceedings of the XI world congress on sarcoidosis and other granulomatous disorders. Amsterdam: Excerpta Medica, 1988: 327–328.
Neville E, Walker AN, James DG. Prognostic factors predicting the outcome of sarcoidosis; an analysis of 818 patients. Q J Med 1983; 52: 525–533.
Huang CT, Heurich AE, Sutton AL, Rosen Y, Lyons HA. Mortality in sarcoidosis. In: Williams JW, Davies BH, eds. Eighth international conference on sarcoidosis and other granulomatous diseases. Cardiff: Alpha Omega, 1980: 522–526.
Iwai K, Taschibana T, Hosoda Y, Matsui Y. Sarcoidosis autopsies in Japan. Sarcoidosis 1988; 5: 60–65.
Sones M, Israel HL. Course and prognosis of sarcoidosis. Am J Med 1960; 29: 84–93.
Battesti JP, Georges R, Basset F, Saumon G. Chronic cor pulmonale in sarcoidosis. Thorax 1978; 33: 76–84.
Sharma OP, Klatt E. Factors which adversely affect the course of sarcoidosis: An analysis of 111 autopsied cases of sarcoidosis. In: Grassi C, Rizzato G, Pozzi E, eds. Sarcoidosis and other granulomatous disorders. Proceedings of the XI world congress on sarcoidosis and other granulomatous disorders. Amsterdam: Excerpta Medica, 1988: 421–422.
Kent DC, Houk VN, Elliot RC, Sokolowisi JW, Baker JH, Sorensen K. The definitive evaluation of sarcoidosis. Am Rev Respir Dis 1970; 101: 721–727.
Aisner SC, Gupta PK, Frost JH. Sputum cytology in pulmonary sarcoidosis. Acta Cytol 1977; 21: 394–398.
Vernon SE. Nodular pulmonary sarcoidosis: diagnosis with fine needle aspiration biopsy. Acta Cytol 1985; 29: 473–476.
Shure D, Fedullo PF. Transbronchial needle aspiration of peripheral masses. Am Rev Respir Dis 1983; 128: 1090–1092.
Frable MA, Frable WJ. Fine needle aspiration biopsy in the diagnosis of sarcoid of the head and neck. Acta Cytol 1984; 28: 175–177.
Selroos O. Fine needle aspiration biopsy of the spleen in diagnosis of sarcoidosis. In: Siltzbach LE, ed. Seventh international conference on sarcoidosis and other granulomatous disorders. Ann NY Acad Sci 1976; 278: 517–521
Fulkerson WJ. Current concepts: Fiberoptic bronchoscopy. N Engl J Med 1984; 311: 511–515.
Teirstein AS, Chuang M, Miller A, Siltzbach LE. Flexible-bronchoscope biopsy of lung and bronchial wall in intrathoracic sarcoidosis. In: Siltzbach LE, ed. Seventh international conference on sarcoidosis and other granulomatous disorders. Ann NY Acad Sci 1976; 278: 522–527.
Koerner SK, Sakowitz AJ, Appelman RI, Becker NH, Schoenbaum SW. Transbronchial lung biopsy for the diagnosis of sarcoidosis. N Engl J Med 1975; 293: 268–270.
Koontz CH, Joyner LR, Nelson RA. Transbronchial lung biopsy via the fiberoptic bronchoscope in sarcoidosis. Ann Intern Med 1976; 85: 64–66.
Khan MA, Corona F, Masson RG. Transbronchial lung biopsy for sarcoidosis. N Engl J Med 1976; 295: 225.
Poletti V, Patelli M, Spiga L, Ferracini R, Manetto V. Transbronchial lung biopsy in pulmonary sarcoidosis; Is it an evaluable method in detection of disease activity? Chest 1986; 89: 361–365.
Gilman MJ, Wang KP. Transbronchial lung biopsy in sarcoidosis. An approach to determine the optimal number of biopsies. Am Rev Respir Dis 1980; 122: 721–724.
Roethe RA, Fuller PB, Byrd RB, Hafermann DR. Transbroncial lung biopsy in sarcoidosis. Chest 1980; 77: 400–402.
Fechner RE, Greenberg SD, Wilson RK, Stevens PM. Evaluation of transbronchial biopsy of the lung. Am J Clin Pathol 1977; 68: 17–20.
Koch ML, Coté RA. Comparison of fluorescense microscopy with Ziehl-Neelsen stain for demonstration of acid fast bacilli. Am Rev Respir Dis 1965; 91: 283–294.
Wellman KF, Teng KP. Demonstration of acid fast bacilli in tissue sections by fluorescense. Can Med Assoc J 1962; 87: 837–841.
Woodard BH, Rosenberg SI, Farnham R, Adams DO. Incidence and nature of primary granulomatous inflammation in surgically removed material. Am J Surg Pathol 1982; 6: 119–129.
Wiley EL, Mulhollan TJ, Beck B, Tyndall JA, Freeman RG. Polyclonal antibodies raised against Bacillus Calmette-Guerin, Mycobacterium duvalii and Mycobacterium paratuberculosis used to detect mycobacteria in tissue with the use of immunohistochemical techniques. Am J Clin Pathol 1990; 94: 307–312.
Eisenach KD, Crawford JT, Bates JH. Repetitive DNA sequences as probes for Mycobacterium tuberculosis. J Clin Microbiol 1988; 26: 2240–2245.
Lin CS, Ruiz A. Contamination by saprophytic acid-fast bacilli in the histology laboratory. Lab Med 1977; 8: 11–13.
Ulbright TM, Katzenstein AA. Solitary necrotizing granulomas of the lung. Am J Surg Pathol 1980; 4: 13–28.
Grange JM. Tuberculosis. In: Wilson G, Miles A, Parker MT, eds. Topley and Wilson’s principles of bacteriology, virology and immunity, Vol 3. Baltimore: Williams & Wilkins, 1983: 42–43.
Boyd WA. A textbook of pathology. 3d Ed. Philadelphia: Lea & Feibiger, 1938.
Gottlieb JA, Fanburg BL, Pauker SG. A decision analytic view of the diagnosis of sarcoidosis. In: Fanburg BL, ed. Sarcoidosis and other granulomatous diseases of the lung. New York: Marcel Dekker, 1983: 349–380.
Williams RH, Nickerson DA. Skin reactions in sarcoid. Proc Soc Exp Biol Med 1935; 33: 403–405.
Siltzbach LE. The Kveim test in sarcoidosis. Am J Med 1961; 30: 495–501.
Chase MW. The preparation and standardization of Kveim antigen. Am Rev Respir Dis 1961; 84 (Part 2): 86–88.
Chapman J. The Kveim test. Arch Pathol Lab Med 1977; 101: 515–517.
Kataria YP. Cutaneous granulomata in response to injection with autoclaved bronchoalveolar lavage cell preparation in sarcoidosis patients. In: Grassi C, Rizzato G, Pozzi E, eds. Sarcoidosis and other granulomatous disorders. Proceedings of the XI world congress on sarcoidosis and other granulomatous disorders. Amsterdam: Excerpta Medica, 1988: 139–142.
Siltzbach LE. Qualities and behavior of satisfactory Kveim suspensions. In: Siltzbach LE, ed. Seventh international conference on sarcoidosis and other granulo-matous disorders. Ann NY Acad Sci 1976; 278: 665–669.
Teirstein AS, Brown LK. The Kveim Siltzbach test in 1987. In: Grassi C, Rizzato G, Pozzi E, eds. Sarcoidosis and other granulomatous disorders. Proceedings of the XI world congress on sarcoidosis and other granuloma-tous disorders. Amsterdam: Excerpta Medica, 1988: 7–18.
Mishra BB, Poulter LW, Sherlock S, James DG. The Kveim. Siltzbach granuloma: A model for sarcoid granuloma formation. In: Johns CJ, ed. Tenth international conference on sarcoidosis and other granulomatous disorders. Ann NY Acad Sci 1986; 465: 164–175.
Kataria YP, Park HK. Dynamics and mechanism of the sarcoidal granuloma: Detecting T cell subsets, non T cells and immunoglobulins in biopsies at varying intervals of Kveim-Siltzbach test sites. In: Johns CJ, ed. Tenth international conference on sarcoidosis and other granulomatous disorders. Ann NY Acad Sci 1986; 465: 221–232.
Cohn ZA, Fedorko ME, Hirsch JG, Turiaf J, Chabot J. In: Turiaf J, Chabot J, James DG, Zatouroff MA, eds. La Sarkoidose. Report of the 4th international conference on sarcoidosis. Paris: Masson et Cie, 1967: 141–149.
Lieberman L. Elevation of serum angiotensin converting enzyme (ACE) in sarcoidosis. Am J Med 1975; 59: 365–372.
Friedland J, Silverstein E. Sensitive fluorometric assay for serum angiotensin-converting enzyme with the natural substrate angiotensin 1. Am J Clin Pathol 1977; 68: 225–228.
Studdy PR, James DG. The specificity and sensitivity of serum angiotensin converting enzyme in sarcoidosis and other diseases. Experience in twelve centres in six different countries. In: Chrétien J, Marsac J, Saltiel JC, eds. Sarcoidosis and other granulomatous disorders. Ninth international conference on sarcoidosis and other granulomatous disorders. Paris: Pergamon Press, 1983: 332–344.
Muthuswamy PP, Lopez-Majano V, Ranginwala M, Trainor WD. Serum angiotensin-converting enzyme (SACE) activity as an indicator of total body granuloma load and prognosis in sarcoidosis. Sarcoidosis 1987; 4: 142–148.
Silverstein E, Friedland J, Lyons HA. Serum angiotensin converting enzyme in sarcoidosis: Clinical significance. Isr J Med Sci 1977; 13: 1001–1006.
Silverstein E, Friedland J, Lyons HA, Gourin A. Markedly elevated angiotensin converting enzyme in lymph nodes containing nonnecrotizing granulomas in sarcoidosis. Proc Natl Acad Sci USA 1976; 73: 2137–2141.
Pertschuk LP, Silverstein E, Friedland J. Detection of angiotensin-converting enzyme in sarcoid granulomas. Am J Clin Pathol 1981; 75: 350–354.
Pertschuk LP, Stanek AE, Silverstein E, Friedland J. Immunocytochemical detection of angiotensin-converting enzyme in sarcoidosis granulomas. In: DeLellis RA, ed. Monographs in diagnostic pathology. Vol. 7. Advances in immunohistochemistry New York: Masson, 1984: 311–323.
Stanek AE, Silverstein E, Friedland J. Angiotensin converting enzyme is localized in the plasma membrane of the epithelioid cell of the sarcoidosis granuloma. Clin Res 1982; 30: 438A.
Silverstein E, Friedland J. Pathogenesis of sarcoidosis; T lymphocyte modulation of induction of angiotensin converting enzyme in human monocytes in culture. Evidence of mediation by lymphokine. In: International committee on sarcoidosis. 10th international conference on sarcoidosis and other granulomatous disorders (abstracts). Baltimore, 1984: 96.
Ryder KW, Stephen JJ, Saleem KO, Meredith HT. Serum angiotensin converting enzyme activity in patients with histoplasmosis. JAMA 1983; 249: 1888–1889.
Check IJ, Gowitt GT, Staton GW. Bronchoalveolar lay-age cell differential in the diagnosis of sarcoid interstitial lung disease: Likelihood ratios based on computerized data base. Am J Clin Pathol 1985; 84: 744–747.
Line BR, Fulmer JD, Reynolds HY, et al. Gallium-67 citrate scanning in the staging of idiopathnic pulmonary fibrosis; correlation with physiologic and morphologic features and bronchoalveolar lavage. Am Rev Respir Dis 1978; 118: 355–365.
Hunninghake GW, Line BR, Szapiel SV, Crystal RG. Activation of inflammatory cells increases the localization of gallium-67 at sites of disease. Clin Res 1981; 29: 171A.
Rizzato G, Blasi A. A European survey on the usefulness of gallium-67 lung scans in assessing sarcoidosis: Experience in 14 research centers in seven different countries. In: Johns CJ, ed. Tenth international conference on sarcoidosis and other granulomatous disorders. Ann NY Acad Sci 1986; 465: 463–478.
Hirsh BC, Johnson WC. Pathology of granulomatous diseases. Epithelioid granulomas, Part 1. Int J Dermatol 1984; 23: 237–246.
Liebow AA. The J Burns Amberson Lecture. Pulmonary angiitis and granulomatosis. Am Rev Respir Dis 1973; 108: 1–118.
Saldana MJ. Necrotizing sarcoid granulomatosis: Clinico-pathologic observations in 24 patients. Lab Invest 1978; 38: 364 (abstract).
Churg A, Carrington CB, Gupta R. Necrotizing sarcoid granulomatosis. Chest 1979;76:406 –413.
Koss MN, Hochholzer L, Feigin DS, Garancis JC, Ward PA. Necrotizing sarcoid-like granulomatosis: Clinical, pathologic and immunopathologic findings. Hum Pathol 1980; 2 (Suppl): 510–519.
Stephen JG, Baimbridge MV, Corrin B, Wilkinson SP, Day D, Whimster WF. Necrotizing “sarcoidal” angiitis and granulomatosis of the lung. Thorax 1976;31:356–253. 242. Menon MPS, Beohar PC, Jain SK, Narayanan SK. Necrotizing sarcoid angiitis and granulomatosis of the lung. Indian J Chest Dis Allied Sci 1980; 22: 123–127.
Fisher MR, Christ ML, Bernstein JR. Necrotizing sarcoid-like granulomatosis: radiologic-pathologic correlation. J Canad Assoc Radiol 1984; 35: 313–315.
Rolfes DB, Weiss MA, Sanders MA. Necrotizing sarcoid granulomatosis with suppurative features. Am J Clin Pathol 1984; 82: 602–607.
Gibbs AR, Jones William W. Necrotising sarcoidal granulmatosis. In: International Committee on Sarcoidosis. Tenth international conference on sarcoidosis and other granulomatous disorders. Abstracts. Baltimore, 1984: 1–2.
Rühl GH, Schlanstein A, Hartung W. Nekrotisierende sarkoidale Granulomatose der Lunge. Prax Klin Pneumol 1985; 39: 284–287.
Weiss M, Gokel JM. Die nekrotisierende sarkoide Granulomatose der Lunge. Pathologe 1990; 11: 178–182.
Sugama Y, Matsuoka R, Kitamura S. A case of necrotizbiopsy. sarcoid granulomatosis diagnosed by open lung biopsy. Jpn J Thorac Dis 1989: 27: 75–80.
Armbruster C, Vetter N. Zur Differentialdiagnose der nekrotisierenden sarkoidalen Angiitis: Nekrotisierende sarkoidale Angiitis und Kollagenerkrankung-ein Fall Putman 1991; 45: 63–66.
Gordon CI. Necrotizing sarcoid granulomatosis: Report of a case. J Am Osteopath Assoc 1986; 584–588.
Katzenstein AA. The histologic spectrum and differential diagnosis of necrotizing granulomatous inflammation in the lung. In: Fenoglio CM, Wolff M, eds. Progress in surgical pathology. Vol. 2. New York: Masson, 1980: 42–70
Cole SR, Johnson KJ, Ward PA. Pathology of sarcoido sisgranulomatous vasculitis and other idiopathic granulomatous diseases of the lung. In: Fanburg BL, ed. Sarcoidosis and other granulomatous diseases of the lung. New York: Marcel Dekker, 1983: 149–202.
Churg A. Pulmonary angiitis and granulomatosis revisited. Hum Pathol 1983; 14: 868–883
Cole SR.Personal communication.
Singh N, Cole SR, Krause PJ,Conway M, Garcia L. Necrotizing sarcoid granulomatosis with extrapulmonary involvement. Am Rev Respir Dis 1981; 124: 189–191
Dail DH. Personal communication
Kirks DR, McCormick VD, Greenspan RH. Pulmonary sarcoidosis. Roentgenologic analysis of 150 patients. AJR 1973; 117: 777–786
Sharma OP,Hewlett R, Cordonson J. Nodular sarcoidosis: an unusual radiographic appearance. Chest 1973; 64: 189–192
Sharma OP. Sarcoidosis: unusual pulmonary manifestations. Postgrad Med 1977; 61: 67–73
Rømer FK.Sarcoidosis with large nodular lesions simulating pulmonary metastases: an analysis of 126 cases of intrathoracic sarcoidosis. Scand J Respir Dis 1977; 58:11–16.
Rose RM, Lee RGL, Costello P. Solitary nodular sarcoiingdosis Clin Radiol 1985; 36: 589–592
Onal E, Lopata M, Lourenco RV. Nodular pulmonary sarcoidosis. Chest 1977; 72: 296–300
Tellis CJ, Putman JS. Cavitation in large multinodular pulmonary disease. Arare manifestation of sarcoidosis Chest 1977; 71: 792–793
Ohsaki Y, Abe S, Yahara O, Murao M. Bilateral hilar lymphadenopathy and cystic lung lesion. Chest 1977; 71: 81–82
Cavallo A, Perin B, Perini L, Natale F. Rara complicanza della sarcoidosi: Cavitazione polmonare. Radiol Med 1987; 73: 589–590
Tada H, Yasumizu R, Yuasa S, Sato M, Mizuno Y. Annular lesion of the lung in sarcoidosis. Thorax 1989; 44: 756–775
Dorcier F, Grenier N, Dubroca J, Lacoste D, Beylot J, Grelet PH. Sarcoïdose thoracique avec «cavitation» pulmonaire. Radiologie 1987; 68: 451–454.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Rosen, Y. (1994). Sarcoidosis. In: Dail, D.H., Hammar, S.P. (eds) Pulmonary Pathology. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-3935-0_19
Download citation
DOI: https://doi.org/10.1007/978-1-4757-3935-0_19
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-3937-4
Online ISBN: 978-1-4757-3935-0
eBook Packages: Springer Book Archive